GASPAR ROSARIO: Open Payments
NPI 1639163470 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 31 payments from 6 companies in 2025. Trend: 2023 $693 · 2024 $412 · 2025 $896
Food & beverage: $896
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $566 |
| Intra-Sana Laboratories | 4 | $170 |
| Corcept Therapeutics | 3 | $65 |
| Lilly USA, LLC | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Currax Pharmaceuticals LLC | 1 | $17 |
Products named: Wegovy, RELTONE 200 MG, Korlym, MOUNJARO, JARDIANCE, Ozempic, CONTRAVE, GLYCATE.
Industry payments across NY — which companies pay providers there.
